語系:
繁體中文
English
說明(常見問題)
回圖書館首頁
手機版館藏查詢
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Technology transfer = drug product m...
~
Pazhayattil, Ajay Babu.
FindBook
Google Book
Amazon
博客來
Technology transfer = drug product manufacturing process /
紀錄類型:
書目-電子資源 : Monograph/item
正題名/作者:
Technology transfer/ by Ajay Babu Pazhayattil ... [et al.].
其他題名:
drug product manufacturing process /
其他作者:
Pazhayattil, Ajay Babu.
出版者:
Cham :Springer International Publishing : : 2023.,
面頁冊數:
xiv, 148 p. :ill. (some col.), digital ;24 cm.
內容註:
Chapter 1: Current Status of Technology Transfer -- Chapter 2: Quality by Design (QbD) Process Design -- Chapter 3: Quality Risk Management (QRM) -- Chapter 4: Technology Transfer Process -- Chapter 5: Scaling-Up of Solid Orals: Granulation, Drying, Size Reduction, Blending, Compression, and Coating Technologies -- Chapter 6: Qualification, Continued Process Verification, and Lifecycle Management -- Chapter 7: Continuous Improvement Case Study: Transforming Legacy Products.
Contained By:
Springer Nature eBook
標題:
Pharmaceutical technology. -
電子資源:
https://doi.org/10.1007/978-3-031-32192-4
ISBN:
9783031321924
Technology transfer = drug product manufacturing process /
Technology transfer
drug product manufacturing process /[electronic resource] :by Ajay Babu Pazhayattil ... [et al.]. - Cham :Springer International Publishing :2023. - xiv, 148 p. :ill. (some col.), digital ;24 cm. - AAPS introductions in the pharmaceutical sciences,102522-8358 ;. - AAPS introductions in the pharmaceutical sciences ;10..
Chapter 1: Current Status of Technology Transfer -- Chapter 2: Quality by Design (QbD) Process Design -- Chapter 3: Quality Risk Management (QRM) -- Chapter 4: Technology Transfer Process -- Chapter 5: Scaling-Up of Solid Orals: Granulation, Drying, Size Reduction, Blending, Compression, and Coating Technologies -- Chapter 6: Qualification, Continued Process Verification, and Lifecycle Management -- Chapter 7: Continuous Improvement Case Study: Transforming Legacy Products.
Currently, there are no textbooks on drug product manufacturing technology transfer that incorporate the latest regulatory expectations. Recent guidance from regulatory bodies such as the US FDA, EMEA, WHO, and PIC/S has adopted the ICH Lifecycle approach harmonizing concepts across regulatory guidance. This allows organizations to align their technology transfer activities for all regulated markets. However, there is a need for consensus and direction in approaching technology transfer, particularly in understanding how to manage the scale-up effects to ensure regulatory compliance. This textbook offers technology transfer solutions and guidance to the pharmaceutical industry. The chapters provide a systematic understanding of applying the technology transfer concepts in pharmaceutical manufacturing, promoting standardization within the industry. Since Stage 1b is not specified in detail within the regulations, pharmaceutical organizations are left to determine the requirements of the stage. The need to justify the methodologies and utilization of sound science makes it more demanding. The textbook's authors provide innovative solutions for technology transfer challenges, making it a comprehensive reference document. The approaches can be applied to both small-molecule and large-molecule drug product manufacturing segments, addressing the unmet needs of the industry.
ISBN: 9783031321924
Standard No.: 10.1007/978-3-031-32192-4doiSubjects--Topical Terms:
562441
Pharmaceutical technology.
LC Class. No.: RS192
Dewey Class. No.: 615.19
Technology transfer = drug product manufacturing process /
LDR
:02957nmm a2200337 a 4500
001
2318378
003
DE-He213
005
20230616163935.0
006
m d
007
cr nn 008maaau
008
230902s2023 sz s 0 eng d
020
$a
9783031321924
$q
(electronic bk.)
020
$a
9783031321917
$q
(paper)
024
7
$a
10.1007/978-3-031-32192-4
$2
doi
035
$a
978-3-031-32192-4
040
$a
GP
$c
GP
041
0
$a
eng
050
4
$a
RS192
072
7
$a
MQP
$2
bicssc
072
7
$a
MED072000
$2
bisacsh
072
7
$a
MQP
$2
thema
082
0 4
$a
615.19
$2
23
090
$a
RS192
$b
.T255 2023
245
0 0
$a
Technology transfer
$h
[electronic resource] :
$b
drug product manufacturing process /
$c
by Ajay Babu Pazhayattil ... [et al.].
260
$a
Cham :
$b
Springer International Publishing :
$b
Imprint: Springer,
$c
2023.
300
$a
xiv, 148 p. :
$b
ill. (some col.), digital ;
$c
24 cm.
490
1
$a
AAPS introductions in the pharmaceutical sciences,
$x
2522-8358 ;
$v
10
505
0
$a
Chapter 1: Current Status of Technology Transfer -- Chapter 2: Quality by Design (QbD) Process Design -- Chapter 3: Quality Risk Management (QRM) -- Chapter 4: Technology Transfer Process -- Chapter 5: Scaling-Up of Solid Orals: Granulation, Drying, Size Reduction, Blending, Compression, and Coating Technologies -- Chapter 6: Qualification, Continued Process Verification, and Lifecycle Management -- Chapter 7: Continuous Improvement Case Study: Transforming Legacy Products.
520
$a
Currently, there are no textbooks on drug product manufacturing technology transfer that incorporate the latest regulatory expectations. Recent guidance from regulatory bodies such as the US FDA, EMEA, WHO, and PIC/S has adopted the ICH Lifecycle approach harmonizing concepts across regulatory guidance. This allows organizations to align their technology transfer activities for all regulated markets. However, there is a need for consensus and direction in approaching technology transfer, particularly in understanding how to manage the scale-up effects to ensure regulatory compliance. This textbook offers technology transfer solutions and guidance to the pharmaceutical industry. The chapters provide a systematic understanding of applying the technology transfer concepts in pharmaceutical manufacturing, promoting standardization within the industry. Since Stage 1b is not specified in detail within the regulations, pharmaceutical organizations are left to determine the requirements of the stage. The need to justify the methodologies and utilization of sound science makes it more demanding. The textbook's authors provide innovative solutions for technology transfer challenges, making it a comprehensive reference document. The approaches can be applied to both small-molecule and large-molecule drug product manufacturing segments, addressing the unmet needs of the industry.
650
0
$a
Pharmaceutical technology.
$3
562441
650
0
$a
Technology transfer.
$3
526217
650
1 4
$a
Pharmacy.
$3
636101
650
2 4
$a
Pharmaceutics.
$3
3538434
650
2 4
$a
Pharmacology.
$3
634543
650
2 4
$a
Drug Delivery.
$3
3531319
650
2 4
$a
Drug Safety and Pharmacovigilance.
$3
2108855
700
1
$a
Pazhayattil, Ajay Babu.
$3
3633346
710
2
$a
SpringerLink (Online service)
$3
836513
773
0
$t
Springer Nature eBook
830
0
$a
AAPS introductions in the pharmaceutical sciences ;
$v
10.
$3
3633347
856
4 0
$u
https://doi.org/10.1007/978-3-031-32192-4
950
$a
Biomedical and Life Sciences (SpringerNature-11642)
筆 0 讀者評論
館藏地:
全部
電子資源
出版年:
卷號:
館藏
1 筆 • 頁數 1 •
1
條碼號
典藏地名稱
館藏流通類別
資料類型
索書號
使用類型
借閱狀態
預約狀態
備註欄
附件
W9454628
電子資源
11.線上閱覽_V
電子書
EB RS192
一般使用(Normal)
在架
0
1 筆 • 頁數 1 •
1
多媒體
評論
新增評論
分享你的心得
Export
取書館
處理中
...
變更密碼
登入